Beta
Back to PATH.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
operating-expenses-chart

PATH Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q4'26, UiPath's (PATH) total operating expenses reached $326.89M USD, comprising $95.16M USD in R&D expenses and $231.73M USD in SG&A expenses, reflecting a slight quarterly decline from Q3'26's $329.23M USD total. Over the period from Q1'24 to Q4'26, R&D expenses exhibited steady growth from $75.34M USD to $95.16M USD, with a notable acceleration in Q2'25 onward, indicating increased investment in innovation. In contrast, SG&A expenses peaked at $257.85M USD in Q2'25 before stabilizing around $220-230M USD, contributing to overall operating expenses fluctuating between $300-350M USD annually, suggesting a maturing cost structure amid business expansion.